![](https://mpfshstrg.blob.core.windows.net/mpf-uat-common-resources/Images/monograph/table.gif)
Pediatric Dose: See Table 2.
![](https://mpfshstrg.blob.core.windows.net/mpf-uat-common-resources/Images/monograph/table.gif)
Switching Patients to or from a Monoamine Oxidase Inhibitor (MAOI): At least 14 days should elapse between discontinuation of a MAOI and initiation of therapy with sertraline. In addition, at least 14 days should be allowed after stopping sertraline before starting a MAOI.
Discontinuing Treatment: Closely monitor patients for symptoms associated with discontinuation of sertraline and other SSRIs and selective norepinephrine reuptake inhibitors (SNRIs).
Gradual dose reduction rather than abrupt cessation of treatment is recommended whenever possible.
Consider resumption of previously prescribed dose if intolerable symptoms occur after a decrease in the dose or upon discontinuation of treatment. Reduction of the dose may be continued but at a more gradual rate.